Elcid Investments Limited (BOM:503681)
135,457
+1,310 (0.98%)
At close: Aug 1, 2025
Augmedix Balance Sheet
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2016 - 2020 |
---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2016 - 2020 |
Cash & Equivalents | 23.15 | 37.13 | 111.02 | 13.32 | 88.16 | Upgrade |
Trading Asset Securities | - | - | 6,608 | 4,089 | 3,281 | Upgrade |
Cash & Short-Term Investments | 23.15 | 37.13 | 6,719 | 4,102 | 3,369 | Upgrade |
Cash Growth | -37.66% | -99.45% | 63.81% | 21.74% | -20.12% | Upgrade |
Other Receivables | - | 6.27 | 1.06 | 0.85 | 0.79 | Upgrade |
Receivables | - | 6.27 | 1.06 | 0.85 | 0.79 | Upgrade |
Prepaid Expenses | - | - | 0.06 | 0.06 | 0.08 | Upgrade |
Other Current Assets | 0.18 | 0.22 | 0.2 | 0.29 | 0.38 | Upgrade |
Total Current Assets | 23.32 | 43.61 | 6,721 | 4,103 | 3,371 | Upgrade |
Property, Plant & Equipment | 318.9 | 264.76 | 161.69 | 168.85 | 158.78 | Upgrade |
Long-Term Investments | 105,707 | 124,490 | 112,556 | 127,504 | 105,024 | Upgrade |
Other Intangible Assets | 7.5 | 8.5 | 9.5 | - | - | Upgrade |
Other Long-Term Assets | 16.97 | 16.59 | 16.79 | 16.32 | 16.33 | Upgrade |
Total Assets | 106,074 | 124,823 | 119,465 | 131,792 | 108,570 | Upgrade |
Accrued Expenses | 0.62 | -0.05 | 0.18 | 0.09 | 1.08 | Upgrade |
Current Income Taxes Payable | 98.01 | 114.88 | 95.58 | 148.12 | 40.08 | Upgrade |
Other Current Liabilities | 1.06 | 2.35 | 2.68 | 1.07 | 1.21 | Upgrade |
Total Current Liabilities | 99.68 | 117.19 | 98.44 | 149.28 | 42.37 | Upgrade |
Long-Term Deferred Tax Liabilities | 14,285 | 7,861 | 7,444 | 8,355 | 6,875 | Upgrade |
Other Long-Term Liabilities | 4.1 | - | 0 | -0 | - | Upgrade |
Total Liabilities | 14,389 | 7,978 | 7,543 | 8,504 | 6,918 | Upgrade |
Common Stock | 2 | 2 | 2 | 2 | 2 | Upgrade |
Retained Earnings | 10,221 | 8,696 | 6,944 | 6,213 | 5,215 | Upgrade |
Comprehensive Income & Other | 81,462 | 108,147 | 104,976 | 117,073 | 96,435 | Upgrade |
Shareholders' Equity | 91,685 | 116,845 | 111,922 | 123,288 | 101,652 | Upgrade |
Total Liabilities & Equity | 106,074 | 124,823 | 119,465 | 131,792 | 108,570 | Upgrade |
Net Cash (Debt) | 23.15 | 37.13 | 6,719 | 4,102 | 3,369 | Upgrade |
Net Cash Growth | -37.66% | -99.45% | 63.81% | 21.74% | -20.12% | Upgrade |
Net Cash Per Share | 115.73 | 185.65 | 33596.05 | 20509.70 | 16847.25 | Upgrade |
Filing Date Shares Outstanding | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | Upgrade |
Total Common Shares Outstanding | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | Upgrade |
Working Capital | -76.36 | -73.58 | 6,622 | 3,954 | 3,328 | Upgrade |
Book Value Per Share | 458425.83 | 584225.20 | 559608.69 | 616440.32 | 508261.02 | Upgrade |
Tangible Book Value | 91,678 | 116,837 | 111,912 | 123,288 | 101,652 | Upgrade |
Tangible Book Value Per Share | 458388.33 | 584182.70 | 559561.19 | 616440.32 | 508261.02 | Upgrade |
Buildings | 279.65 | 235.97 | 144.26 | 144.26 | 141.57 | Upgrade |
Machinery | 67.37 | 46.91 | 36.91 | 36.91 | 23.55 | Upgrade |
Updated Jan 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.